Nicholaus Williams is Head of Finance at Encoded Therapeutics, where he oversees the finance, accounting and information technology functions. With a career in finance spanning over twenty years, Nicholaus brings valuable expertise to his role. Prior to joining Encoded, Nicholaus served as the VP of Finance at Dermira, Inc., a publicly traded, commercial-stage company. Prior to his tenure at Dermira, he held a series of different finance-related positions of increasing responsibility at InterMune, Inc., Onyx Pharmaceuticals, Inc., and Amgen Inc. He began his career as a financial analyst at The Gillette Company (now Procter & Gamble). Nicholaus earned his B.S. in Finance from NC A&T State University and his M.B.A. from Pepperdine University.